Ascendis Pharma A-S
Price & Volume
Stats
See moreOpen | $210.23 |
Previous Close | $210.13 |
Day Range | $209.33-$213.95 |
52W Range | $118.03-$214.71 |
Market Cap | $12.7B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $490.7M |
Revenue Growth (YoY) | 339% |
Gross Profit (12 Mos) | $416.5M |
Diluted EPS | -$5.31 |
News
See moreYahoo Finance • 6 hours ago
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
Yahoo Finance • yesterday
Ascendis Submits Marketing Authorisation Application to the European Medicines Agency for TransCon® CNP for Treatment of Children with Achondroplasia
Yahoo Finance • 9 days ago
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
Yahoo Finance • last month
Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
About
CEO | Mr. Jan Moller Mikkelsen |
CFO | Mr. Scott T. Smith |
Address | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,017 |
